Prognostic Significance and Temporal Patterns of Glycemic Variability in Critically Ill Non-Diabetic Patients with Ischemic Stroke: A Retrospective Multicenter Cohort Study - Scorecard - MDSpire
Advertisement
Prognostic Significance and Temporal Patterns of Glycemic Variability in Critically Ill Non-Diabetic Patients with Ischemic Stroke: A Retrospective Multicenter Cohort Study
Clinical Scorecard: Prognostic Implications and Temporal Trends of Glycemic Variability in Non-Diabetic Ischemic Stroke Patients in Critical Condition: A Retrospective Analysis Across Multiple Centers
At a Glance
Category
Detail
Condition
Key Mechanisms
Glycemic variability (GV) as a dynamic metabolic marker associated with increased mortality risk.
Target Population
Care Setting
Key Highlights
Nonlinear association observed with GV and mortality risk, indicating a critical threshold.
Guideline-Based Recommendations
Diagnosis
Management
Monitor and manage blood glucose fluctuations in ND-IS patients, considering specific interventions for high GV.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Elevated GV indicates a need for closer monitoring and potential intervention, such as insulin therapy.
Clinical Best Practices
Incorporate GV assessment into routine monitoring of ND-IS patients, ideally every 6 hours.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.